The theory of resource dependence states that "managers may think they control the flow of resources in their firms, but in the end it is really the cus- tomers and investors who dictate how money will be spent because companies with investment patterns that don't satisfy their customers and...
Over a dozen content experts representing decades of expertise and experience in clinical trial operations, pharmaceutical companies, federal regulations, community engagement, organizational readiness, and maturity model building. Feedback revealed the need to ensure robust quantitative and qualitative measureme...
Over 200 companies world-wide are now working to develop cell-based therapies. Concluding remarks When I came to the National Cancer Institute on July 1, 1974 as Chief of the Surgery Branch (a position I have held continuously for the past 46 years) little if anything was known about the ...
Out of class activities • Encourage internships in local, state, or federal govern- ment that concern public policy and technology as much as you push traditional technical outlets like research experiences for undergraduates or employment at engi- neering companies. • Encourage a group of ...
European standards on air emissions (Fig.10b) [50].The project is the result of a partnership between the Government of Ethiopia and a consortium of international companies: Cambridge Industries Limited (Singapore), China National Electric Engineering and Ramboll, a Danish engineering firm and ...
Future studies are also recommended to consider potential changes in medical AI readiness over time to improve medical AI knowledge and skills among medical students to ensure a healthy AI ecosystem that leads to the development of innovative AI technologies and companies....
Generic entry causes the market share of originator drugs to fall; however, this coincides with originator companies launching new branded reformulations which are promoted just prior to generic entry [68]. The entry of a generic paroxetine (an SSRI anti-depressant) lowered the price of the ...
Comparison of sales income and research and development costs for FDA-approved cancer drugs sold by originator drug companies. JAMA Netw Open. 2019;2(1):e186875. https://doi.org/10.1001/jamanetworkopen.2018.6875. Article PubMed PubMed Central Google Scholar Prasad V, Mailankody S. Research ...
Though no FDA-approved drugs currently target epitranscriptomic regulators, there is preclinical evidence of the anti-tumor effects of RNA-modifying therapy and a growing cadre of interested biotech companies [103]. Most small molecule inhibitors for RNA-modifying therapy have been developed against m6A...
A study of soldiers from two companies of the Israel Defense Forces taking a ground navigation course found added benefit from daily after-action reviews of both successes and failures, compared with those who reviewed only failures [26]. Both the United States Department of Veterans Affairs (VA...